BOSTON, March 25, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

Poster presentation will highlight the potential of ZL-6201 as an innovative antibody-drug conjugate (ADC) for the treatment of sarcoma and other leucine-rich repeat-containing protein 15 ...

-- Jeffrey M. Statland, M.D., Professor of Neurology, University of Kansas Medical Center, and FORTITUDE trial investigator, will present topline del-brax data from dose escalation cohorts in oral ...

I-Mab will present clinical updates on givastomig at the Jefferies Global Healthcare Conference and share new data at ESMO 2025. I-Mab, a U.S.-based biotech company specializing in precision ...

Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) PatientsFLORHAM PARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE ...

- Mini oral presentation to highlight initial Phase 1 data of INCA33890, a promising TGFßR2×PD-1-directed bispecific antibody, in patients with advanced or metastatic solid tumors - Oral presentation ...

A longtime anti-vaccine activist gave a presentation at the Centers for Disease Control and Prevention’s vaccine advisory committee meeting Thursday about an issue that has long been considered ...